126 related articles for article (PubMed ID: 33324981)
1. Uronic acid metabolic process-related gene expression-based signature predicts overall survival of glioma.
Feng Y; Li G; Shi Z; Yan X; Li R; Zhai Y; Chang Y; Wang D; Kahlert UD; Zhang W; Yuan F
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33324981
[TBL] [Abstract][Full Text] [Related]
2. A novel methylation signature predicts radiotherapy sensitivity in glioma.
Feng Y; Li G; Shi Z; Yan X; Wang Z; Jiang H; Chen Y; Li R; Zhai Y; Chang Y; Zhang W; Yuan F
Sci Rep; 2020 Nov; 10(1):20406. PubMed ID: 33230136
[TBL] [Abstract][Full Text] [Related]
3. A five-microRNA signature for individualized prognosis evaluation and radiotherapy guidance in patients with diffuse lower-grade glioma.
Zhang JH; Hou R; Pan Y; Gao Y; Yang Y; Tian W; Zhu YB
J Cell Mol Med; 2020 Jul; 24(13):7504-7514. PubMed ID: 32412186
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
[TBL] [Abstract][Full Text] [Related]
5. Amino acid metabolism-related gene expression-based risk signature can better predict overall survival for glioma.
Liu YQ; Chai RC; Wang YZ; Wang Z; Liu X; Wu F; Jiang T
Cancer Sci; 2019 Jan; 110(1):321-333. PubMed ID: 30431206
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatic Profiling Identifies a Fatty Acid Metabolism-Related Gene Risk Signature for Malignancy, Prognosis, and Immune Phenotype of Glioma.
Qi Y; Chen D; Lu Q; Yao Y; Ji C
Dis Markers; 2019; 2019():3917040. PubMed ID: 31885736
[TBL] [Abstract][Full Text] [Related]
7. Development of Autophagy Signature-Based Prognostic Nomogram for Refined Glioma Survival Prognostication.
Fan Y; Peng X; Li B; Zhao G
Biomed Res Int; 2020; 2020():1872962. PubMed ID: 32964017
[TBL] [Abstract][Full Text] [Related]
8. Transcriptomic Profiling Identifies a DNA Repair-Related Signature as a Novel Prognostic Marker in Lower Grade Gliomas.
Zeng F; Liu X; Wang K; Zhao Z; Li G
Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):2079-2086. PubMed ID: 31533943
[TBL] [Abstract][Full Text] [Related]
9. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
Front Immunol; 2020; 11():603341. PubMed ID: 33363544
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of a seven-microRNA classifier as a novel biomarker for the prediction and detection of recurrence in glioma patients.
Chen W; Yu Q; Chen B; Lu X; Li Q
Oncotarget; 2016 Aug; 7(33):53392-53413. PubMed ID: 27438144
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of a nine-gene signature in glioma patients based on mRNA expression profiling.
Bao ZS; Li MY; Wang JY; Zhang CB; Wang HJ; Yan W; Liu YW; Zhang W; Chen L; Jiang T
CNS Neurosci Ther; 2014 Feb; 20(2):112-8. PubMed ID: 24279471
[TBL] [Abstract][Full Text] [Related]
12. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma.
Zhao J; Wang L; Wei B
Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843
[TBL] [Abstract][Full Text] [Related]
13. N6-methyladenine-related genes affect biological behavior and the prognosis of glioma.
Qu S; Chen Z; Liu B; Liu J; Wang H
Cancer Med; 2021 Jan; 10(1):98-108. PubMed ID: 33264518
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive profiling identifies a novel signature with robust predictive value and reveals the potential drug resistance mechanism in glioma.
Zeng F; Wang K; Liu X; Zhao Z
Cell Commun Signal; 2020 Jan; 18(1):2. PubMed ID: 31907037
[TBL] [Abstract][Full Text] [Related]
15. A robust two-gene signature for glioblastoma survival prediction.
Pan Y; Zhang JH; Zhao L; Guo JC; Wang S; Zhao Y; Tao S; Wang H; Zhu YB
J Cell Biochem; 2020 Jul; 121(7):3593-3605. PubMed ID: 31960992
[TBL] [Abstract][Full Text] [Related]
16. Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma.
Wang P; Wu M; Tu Z; Tao C; Hu Q; Li K; Zhu X; Huang K
Front Oncol; 2020; 10():1119. PubMed ID: 32974125
[No Abstract] [Full Text] [Related]
17. Identification and validation of RNA-binding protein-related gene signature revealed potential associations with immunosuppression and drug sensitivity in glioma.
Chen Z; Wu H; Yang H; Fan Y; Zhao S; Zhang M
Cancer Med; 2021 Oct; 10(20):7418-7439. PubMed ID: 34482648
[TBL] [Abstract][Full Text] [Related]
18. High TRAF3IP3 Level Predicts Poor Prognosis of Patients with Gliomas.
Yang G; Tang S; Zhang J; Qin L
World Neurosurg; 2021 Apr; 148():e436-e449. PubMed ID: 33444836
[TBL] [Abstract][Full Text] [Related]
19. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of a nine-gene signature in glioma patients based on tumor-associated macrophages expression profiling.
Shan X; Zhang C; Wang Z; Wang K; Wang J; Qiu X; Jiang T; Yang P
Clin Immunol; 2020 Jul; 216():108430. PubMed ID: 32325251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]